Capricor Therapeutics (CAPR) Shares Issued (2016 - 2025)
Historic Shares Issued for Capricor Therapeutics (CAPR) over the last 17 years, with Q3 2025 value amounting to $6950.0.
- Capricor Therapeutics' Shares Issued fell 9999.07% to $6950.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $80.9 million, marking a year-over-year increase of 178.54%. This contributed to the annual value of $152.3 million for FY2024, which is 49698.02% up from last year.
- Latest data reveals that Capricor Therapeutics reported Shares Issued of $6950.0 as of Q3 2025, which was down 9999.07% from $19580.0 recorded in Q2 2025.
- Capricor Therapeutics' 5-year Shares Issued high stood at $80.8 million for Q4 2024, and its period low was -$1543.0 during Q4 2021.
- In the last 5 years, Capricor Therapeutics' Shares Issued had a median value of $1.8 million in 2022 and averaged $11.6 million.
- As far as peak fluctuations go, Capricor Therapeutics' Shares Issued plummeted by 10010.75% in 2021, and later soared by 80372929.36% in 2022.
- Capricor Therapeutics' Shares Issued (Quarter) stood at -$1543.0 in 2021, then soared by 803729.29% to $12.4 million in 2022, then crashed by 98.22% to $221081.0 in 2023, then surged by 36465.61% to $80.8 million in 2024, then tumbled by 99.99% to $6950.0 in 2025.
- Its last three reported values are $6950.0 in Q3 2025, $19580.0 for Q2 2025, and $50354.0 during Q1 2025.